Spots Global Cancer Trial Database for breast cancer invasive
Every month we try and update this database with for breast cancer invasive cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study | NCT05019989 | Breast Cancer I... | Intervention gr... Control group: ... | 35 Years - 70 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value) | NCT06401304 | Breast Cancer Breast Carcinom... Breast Cancer I... Breast Asymmetr... | 18 Years - | Uppsala University | ||
| Neoadjuvant Pyrotinib Versus Placebo Combined With Chemotherapy in HR-positive and HER2-low Early Breast Cancer | NCT06144944 | Breast Cancer I... Hormone-recepto... HER2 Low Breast... Early-stage Bre... | Pyrotinib, epir... Placebo, epirub... | 17 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab | NCT05877859 | Breast Cancer T... Breast Cancer S... Breast Cancer S... Breast Cancer I... | 18 Years - | Emory University | ||
| Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value) | NCT06401304 | Breast Cancer Breast Carcinom... Breast Cancer I... Breast Asymmetr... | 18 Years - | Uppsala University | ||
| Ultrasound Imaging, Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment. | NCT00437879 | Breast Cancer I... | - | Sunnybrook Health Sciences Centre | ||
| Milademetan in Advanced/Metastatic Solid Tumors | NCT05012397 | Solid Tumors Head and Neck C... Cholangiocarcin... Sarcoma Lung Adenocarci... Bladder Urothel... Stomach Adenoca... Breast Cancer I... Ovarian Carcino... Cervical Cancer Non Small Cell ... Gastric Cancer Biliary Tract C... Melanoma Pancreas Cancer MDM2 Gene Ampli... Testicular Germ... Adrenocortical ... | RAIN-32 | 18 Years - | Rain Oncology Inc | |
| Immature Granulocyte Count and Delta Neutrophil Index Factors for Axillary Metastasis of Breast Cancer | NCT04729647 | Breast Cancer Breast Cancer I... | Mastectomy | 18 Years - | Kahramanmaras Sutcu Imam University | |
| Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy | NCT06268665 | Breast Cancer Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... Invasive Breast... Ovarian Cancer Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Breast Cancer S... Breast Cancer I... Breast Cancer, ... Breast Cancer, ... Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... Cancer, Breast Tumors, Breast Mammary Cancer Mammary Carcino... Breast Carcinom... Breast Neoplasm Malignant Breas... Malignant Tumor... Cancer of Ovary Ovary Cancer Ovary Neoplasm | Tart Cherry Jui... | 18 Years - | University of California, Davis | |
| Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer | NCT05020860 | Breast Cancer Breast Neoplasm Breast Cancer F... Breast Cancer I... Breast Cancer S... Breast Cancer S... Triple Negative... Hormone Recepto... HER2-positive B... Triple Negative... Estrogen Recept... | Paclitaxel Carboplatin Trastuzumab Pertuzumab Doxorubicin Cyclophosphamid... Pembrolizumab Pertuzumab/Tras... | 18 Years - | Baylor Breast Care Center | |
| Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer | NCT05910398 | Breast Cancer I... | pyrotinib | 18 Years - 70 Years | RenJi Hospital | |
| Fluorescence Guided Surgery in Breast Cancer - The MARGIN-2 Study | NCT05939310 | Breast Cancer Breast Cancer I... | Fluorescence gu... | 18 Years - | University Medical Center Groningen | |
| Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer | NCT04999917 | Breast Cancer Breast Cancer I... Breast Cancer i... | high-resolution... | 18 Years - | XEOS Medical | |
| Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST) | NCT05505357 | Breast Cancer I... | Breast surgery ... | 20 Years - | Seoul National University Hospital | |
| Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy. | NCT03627988 | Breast Cancer I... | Patients with i... | 18 Years - | Institut Claudius Regaud | |
| Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial) | NCT03664895 | Breast Cancer I... | Leuplin or zola... | 20 Years - 45 Years | Seoul National University Hospital | |
| Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value) | NCT06401304 | Breast Cancer Breast Carcinom... Breast Cancer I... Breast Asymmetr... | 18 Years - | Uppsala University | ||
| No Axillary Surgery for Early Breast Cancer. | NCT03669705 | Breast Cancer I... | Omitting axilla... | - | Lund University | |
| Neoadjuvant Pyrotinib Versus Placebo Combined With Chemotherapy in HR-positive and HER2-low Early Breast Cancer | NCT06144944 | Breast Cancer I... Hormone-recepto... HER2 Low Breast... Early-stage Bre... | Pyrotinib, epir... Placebo, epirub... | 17 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study | NCT05463276 | Breast Cancer Breast Neoplasm... Breast Cancer I... Breast Cancer S... Breast Cancer M... | 18 Years - 80 Years | Sindh Institute of Urology and Transplantation | ||
| Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study | NCT05019989 | Breast Cancer I... | Intervention gr... Control group: ... | 35 Years - 70 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study | NCT05019989 | Breast Cancer I... | Intervention gr... Control group: ... | 35 Years - 70 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial) | NCT03664895 | Breast Cancer I... | Leuplin or zola... | 20 Years - 45 Years | Seoul National University Hospital | |
| Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer | NCT04999917 | Breast Cancer Breast Cancer I... Breast Cancer i... | high-resolution... | 18 Years - | XEOS Medical | |
| Ultrasound Imaging, Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment. | NCT00437879 | Breast Cancer I... | - | Sunnybrook Health Sciences Centre | ||
| Neoadjuvant Pyrotinib Versus Placebo Combined With Chemotherapy in HR-positive and HER2-low Early Breast Cancer | NCT06144944 | Breast Cancer I... Hormone-recepto... HER2 Low Breast... Early-stage Bre... | Pyrotinib, epir... Placebo, epirub... | 17 Years - 70 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study | NCT06234488 | Breast Cancer Breast Neoplasm... Breast Adenocar... Breast Cancer S... Breast Cancer S... Breast Cancer I... Breast Cancer i... | 18 Years - | Medical College of Wisconsin |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
